• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Stigmatizing Smoking: An Effective Deterrent?

Stigmatizing Smoking: An Effective Deterrent?

March 30, 2020
Benjamin Oldfield, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Benjamin Oldfield, MD Dr. Oldfield has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Cortland CI et al, Addiction 2019;114:1842–1848

Tobacco use is the single most preventable cause of death, disease, and disability in the United States. Among the $50 million the American government spends each year on tobacco cessation efforts, part of that money is spent on public service campaigns that work to shame or stigmatize smoking as an undesirable behavior. This study investigates how the social stereotype threat—creating concern about being judged unfavorably by others—may impact one’s ability to resist the next cigarette.

In this randomized controlled trial, 77 non-treatment-seeking, otherwise healthy adult smokers were recruited from the community and randomized to receive a stereotype threat or a control message after 12 hours of abstinence. Specifically, the stereotype threat group was told that the investigators were interested in “whether non-smokers are superior across all positive traits or only certain types [such as] willpower, laziness, weakness, and responsibility,” bringing to participants’ minds the negative stereotypes of people who smoke. Both the intervention and control groups were given a lighter, an ashtray, some of their favorite cigarettes, and a small monetary reward for delaying smoking during hour-long observation periods.

The investigators did not find any significant difference in time-to-smoke data between the intervention and control groups. However, when the investigators controlled for baseline latency-to-smoke, they discovered that the stereotype threat was associated with lesser latency-to-smoke (hazard ratio 0.50, confidence interval 0.30–0.85). The researchers concluded that the stereotype threat actually functioned as a “smoking-promoting message.”

Major limitations of the study include the short length of the observation period and the simplicity of the stereotype threat, which may not well approximate the complex and multifaceted nature of stereotypes in specific communities and in society at large. Another major limitation is that the control group did not receive a non-threat, smoking-related cue.

CATR’s Take
While it doesn’t readily approximate the complex nature of stereotype or stigma, this study suggests that shaming people may increase their likelihood of lighting up. Although public health messaging that focuses on the harms of smoking can be effective, addiction treatment providers should work to minimize shame and stigma in their patients and in society.
Addiction Treatment
KEYWORDS prevention public-health stigma tobacco-use-disorder
Benjamin Oldfield, MD

Note From the Editor-in-Chief

More from this author
www.thecarlatreport.com
Issue Date: March 30, 2020
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Substance Use in Health Professionals, CATR, March/April 2020
Reducing the Stigma of Addiction Through Language and Terminology
Personal Privacy Versus Public Safety: Addiction Among Health Professionals
Learning From the Successes of Physician Health Programs
Stigmatizing Smoking: An Effective Deterrent?
Predicting and Preventing Fatal Opioid Overdoses
Highlights From This Issue
Featured Book
  • PracticeBoosters2e.JPG

    Psychiatry Practice Boosters, Second Edition (2018)

    Teaches you the key points of 42 of the most clinically relevant studies in psychiatry published...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • Substance_Use_Sites.jpeg
    Addiction Treatment

    Supervised Drug Consumption Sites

    Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.